Achieve Life Sciences (ACHV) Intangibles (2016 - 2026)
Achieve Life Sciences' (ACHV) quarterly Intangibles came in at $696000.0 in Q1 2026, down 24.18% YoY from $918000.0 in Q1 2025, and down 7.32% on a QoQ basis from $751000.0 in Q4 2025.
Analysis
Achieve Life Sciences (ACHV) Intangibles (2016 - 2026) Analysis & Trends
Achieve Life Sciences (ACHV) has 11 years of Intangibles data on file, last reported at $696000.0 in Q1 2026.
- Quarterly Intangibles fell 24.18% year-over-year to $696000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $696000.0 (down 24.18% YoY) and the FY2025 annual result came in at $751000.0, down 22.9% from the prior year.
- Intangibles fell to $696000.0 in Q1 2026, from $751000.0 in the prior quarter.
- In the past five years, Intangibles ranged from a high of $1.6 million in Q1 2022 to a low of $696000.0 in Q1 2026.
- A 5-year average of $1.1 million and a median of $1.1 million in 2024 frame the typical range for Intangibles.
- The widest YoY moves for Intangibles: up 12.33% in 2022, down 50.91% in 2022.
- Tracing ACHV's Intangibles over 5 years: stood at $1.4 million in 2022, then decreased by 15.59% to $1.2 million in 2023, then fell by 18.63% to $974000.0 in 2024, then fell by 22.9% to $751000.0 in 2025, then dropped by 7.32% to $696000.0 in 2026.
- The last three Intangibles figures came in at $696000.0 (Q1 2026), $751000.0 (Q4 2025), and $807000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 63.28 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 60.96 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 93.49 Mn |
| 10 | Achieve Life Sciences | 369.90 Mn | 369.90 Mn | - | 640,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 640,000.00 |
| Mar 31, 2026 | 696,000.00 |
| Dec 31, 2025 | 751,000.00 |
| Sep 30, 2025 | 807,000.00 |
| Jun 30, 2025 | 863,000.00 |
| Mar 31, 2025 | 918,000.00 |
| Dec 31, 2024 | 974,000.00 |
| Sep 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | 1.09 Mn |
| Mar 31, 2024 | 1.14 Mn |
| Dec 31, 2023 | 1.20 Mn |
| Sep 30, 2023 | 1.25 Mn |
| Jun 30, 2023 | 1.31 Mn |
| Mar 31, 2023 | 1.36 Mn |
| Dec 31, 2022 | 1.42 Mn |
| Sep 30, 2022 | 1.48 Mn |
| Jun 30, 2022 | 1.53 Mn |
| Mar 31, 2022 | 1.59 Mn |
| Dec 31, 2021 | 1.64 Mn |
| Sep 30, 2021 | 1.70 Mn |